Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) traded up 3.7% during trading on Tuesday . The company traded as high as C$0.56 and last traded at C$0.56. 10,000 shares were traded during trading, a decline of 54% from the average session volume of 21,969 shares. The stock had previously closed at C$0.54.
Crescita Therapeutics Price Performance
The stock has a 50 day moving average of C$0.58 and a two-hundred day moving average of C$0.57. The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37. The firm has a market capitalization of C$10.85 million, a P/E ratio of -3.73 and a beta of 1.69.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Stories
- Five stocks we like better than Crescita Therapeutics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How Technical Indicators Can Help You Find Oversold Stocks
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Best Stocks Under $10.00
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
